Alternative splicing is a ubiquitous regulatory mech anism of gene expression that allows generation of more than one unique mRNA species from a single gene. Alternative splicing can generate mRNAs that differ in their untranslated regions (UTRs) or coding sequence through mechanisms that include exon skipping (the removal of specific exons, referred to as cassette exons), a choice between mutually exclusive exons, the use of alternative splice sites (which affects the boundaries between introns and exons that are involved in this alter native splicing event, contributing to transcript diversity) and intron retention. These differences might affect mRNA stability, localization or translation. Furthermore, some splicing mRNA isoforms could change the reading frame, resulting in the generation of different protein isoforms with diverse functions and/or localizations. Genomewide studies estimated that 90-95% of human genes undergo some level of alternative splicing 1, 2 . Out of the ~20,000 human proteincoding genes, high resolution mass spectrometry analyses revealed that ~37% of them generate multiple protein isoforms 3 , indi cating that alternative splicing contributes to proteome complexity. However, further work is needed to identify the functional consequences of most of the identified splicing events. In addition, not all alternative splicing events necessarily result in the production of functional proteins. There are several reasons for this: first, the tran script could be noncoding and therefore is not translated into a protein; second, RNA stability could be affected; and third, mRNA localization changes could prevent the correct function of the transcript and/or protein. Adding another level of complexity, it is possible for alternatively spliced transcripts to be noncoding but still have a func tion: for example, they may modulate other RNAs by competing with them for their regulators. It should be noted, however, that nucleic acid amplification methods can overestimate splicing events.
Alternative splicing is a ubiquitous regulatory mech anism of gene expression that allows generation of more than one unique mRNA species from a single gene. Alternative splicing can generate mRNAs that differ in their untranslated regions (UTRs) or coding sequence through mechanisms that include exon skipping (the removal of specific exons, referred to as cassette exons), a choice between mutually exclusive exons, the use of alternative splice sites (which affects the boundaries between introns and exons that are involved in this alter native splicing event, contributing to transcript diversity) and intron retention. These differences might affect mRNA stability, localization or translation. Furthermore, some splicing mRNA isoforms could change the reading frame, resulting in the generation of different protein isoforms with diverse functions and/or localizations. Genomewide studies estimated that 90-95% of human genes undergo some level of alternative splicing 1, 2 . Out of the ~20,000 human proteincoding genes, high resolution mass spectrometry analyses revealed that ~37% of them generate multiple protein isoforms 3 , indi cating that alternative splicing contributes to proteome complexity. However, further work is needed to identify the functional consequences of most of the identified splicing events. In addition, not all alternative splicing events necessarily result in the production of functional proteins. There are several reasons for this: first, the tran script could be noncoding and therefore is not translated into a protein; second, RNA stability could be affected; and third, mRNA localization changes could prevent the correct function of the transcript and/or protein. Adding another level of complexity, it is possible for alternatively spliced transcripts to be noncoding but still have a func tion: for example, they may modulate other RNAs by competing with them for their regulators. It should be noted, however, that nucleic acid amplification methods can overestimate splicing events.
Studies of alternative splicing have now progressed from recording single splicing events and their impact on protein expression to describing global alternative splicing networks and how they are molecularly coordin ated. However, although there has been rapid progress in uncovering the regulatory aspects of alternative splicing networks, there has been relatively little demonstration of their functional consequences. Therefore, understanding the physiological relevance of alternative splicing is one of the biggest challenges of the field
.
It is now established that alternative splicing contrib utes to cell differentiation and lineage determination, tissueidentity acquisition and maintenance, and organ development 2 . The biological importance of alterna tive splicing is further highlighted by the large number of human diseases caused by mutations in cisacting sequence elements in precursor mRNA (premRNA) (including 5ʹ and 3ʹ splice sites, and exonic and intronic enhancer or silencer sequences), transacting splicing factors or other components of the spliceosome 4 . Studies of tissue and organ development are particularly well suited to identifying the functional relevance of splicing networks, as the regulation of cell fate decisions is crucial for tissue and organ function, and governs the transition from embryonic to adult functions 5 . Improved molecular understanding of the splicing transitions that take place during development has also revealed insights into the mechanisms by which normal networks are misregulated in disease.
Here, we review the current knowledge about the physiological contribution of alternative splicing to tissue identity acquisition, organ development and tissue and organ physiology. First, we briefly describe the different layers of splicing regulation and coordination, then dis cuss recent discoveries demonstrating that the coordin ation of alternative splicing networks contributes to the development of various organs, including the brain, heart, 1 Spliceosome A large, macromolecular complex composed of small nuclear RNAs and protein factors that removes regions (mostly introns) from transcribed precursor mRNA.
Alternative splicing as a regulator of development and tissue identity Francisco E. Baralle 1 and Jimena Giudice [2] [3] [4] Abstract | Alternative splicing of eukaryotic transcripts is a mechanism that enables cells to generate vast protein diversity from a limited number of genes. The mechanisms and outcomes of alternative splicing of individual transcripts are relatively well understood, and recent efforts have been directed towards studying splicing networks. It has become apparent that coordinated splicing networks regulate tissue and organ development, and that alternative splicing has important physiological functions in different developmental processes in humans.
R N A P R O C E S S I N G A N D M O D I F I C AT I O N S
RNA-binding proteins (RBPs) . Proteins that bind to RNA molecules through RNA-recognition motifs and exert nuclear and cytoplasmic post-transcriptional functions.
skeletal muscle and liver. We also describe several notable examples of the role of alternative splicing in maintain ing tissue homeostasis and cell function. This article does not cover the role of alternative splicing in epithelialmesenchymal transition or its relevance to cancer: the reader is instead referred to outstanding reviews on these topics 6, 7 . The deregulation of splicing in disease has been extensively reviewed elsewhere 4, 8, 9 , and thus we focus here on the physiological context. We only briefly discuss some developmental disorders for which the functional impact of defective splicing has been demonstrated.
Alternative splicing regulation
Alternative splicing outcomes (that is, the relative abun dance of the different alternatively spliced isoforms) are influenced by several factors: first, splice site strength; second, cisregulatory sequences in premRNAs that favour or impair exon recognition; and third, the expres sion levels of transacting factors (RNA-binding proteins (RBPs) and splicing factors). Strong splice sites contain consensus sequences that are recognized by the spliceo some machinery and usually lead to 'constitutive splicing': that is, the inclusion of the exon in question in all of the mRNA molecules synthesized by the cell. However, con stitutive exons containing nonconsensus splice sites also occur frequently, and their reproducible retention is mediated by additional splicing regulatory elements. Weak splice sites differ from consensus sequences, and their recognition by the spliceosome is highly dependent on the presence of cisacting sequences and the cellular context, such as splicingfactor expression levels.
During tissue development and cell differentiation, specific RBPs are finely regulated in terms of their expression levels, localization, their own splicing, mRNA stability and translation efficiency. RBPs bind to ciselements and promote or inhibit splice site recognition, hence RBP expression coordinates alternative splicing networks during development (Supplementary informa tion S1 (table) ). Microarray analysis and, more recently, RNAsequencing studies have globally described transcriptional and posttranscriptional dynamics in develop ment, including those involving alternative splic ing events (TABLE 1) . These studies have provided sev eral important insights: first, splicing transitions occur during development and cell differentiation in multi ple genes at the same time (splicing coordination); second, specific RBPs contribute to this coordination; third, genes that are regulated by alternative splicing mech anisms are not modulated in terms of their overall expression levels (up or downregulation); and fourth, developmental splicing networks are celltype and/or regionspecific in different tissues (for example, differ ences have been observed between the cerebral cortex and hippocampus, as well as between different neuronal cell types in the brain, between cardiomyocytes and car diac fibroblasts in the heart, and between hepatocytes and nonparenchymal cells in the liver) [10] [11] [12] [13] [14] [15] . Regardless of the expression patterns of RBPs in dif ferent tissues, a 'splicing code' (combinations of RNA features associated with the regulation of splicing) has been proposed to predict splicing outcomes in specific cell types and conditions 16, 17 . Deciphering this splicing code is not trivial: the same regulatory sequences on different or the same transcripts can be recognized by different RBPs depending on cellular and specific sequence contexts; RBPs can be regulated by other RBPs; the same RBP can exert positive or negative regulatory effects on different splicing events depending on the location of the binding motif for the RBP relative to the alternatively spliced regions in the transcript; and, last but not least, we still lack a complete list of RBPs and their binding sites 18 . Furthermore, predicting splicing patterns solely on the basis of premRNA sequences is especially difficult in tissues because they are composed of different cell types, each of which may have unique splicing regulatory networks 18 .
Box 1 | From individual splicing events to coordinated splicing networks
Advances in genomics have allowed the transition from cloning individual splice isoforms to describing alternatively spliced transcripts at the global level. The first generation of transcriptomic analyses used microarrays to identify groups of splicing events involved in tissue formation, function and pathology, as well as events controlled by certain signalling cascades. More recently, deep RNA sequencing has revealed in an unbiased manner how alternative splicing is coordinated during development and cell differentiation, and in disease. Complementary studies aim to understand the roles of alternative splicing; studies of the functions of alternatively spliced isoforms in the nervous system have been particularly insightful. Some exciting data have also been collected in the context of cardiac and skeletal muscle development, as well as in relation to heart disease and muscular dystrophy. However, much more work is required. A very limited number of splicing variants have been associated with particular functions in vivo so far, and the number of splicing isoforms with unknown and even unexplored functions exponentially increases.
Fibronectin (FN1) was one of the first genes for which alternative splicing was described and its mechanism studied. The figure illustrates an early finding regarding a specific alternative splicing event in FN1 transcript, namely the retention or exclusion of the extradomain-A exon (EDA; dashed lines), which controls FN1 tissue localization. EDA-containing protein (referred to as cellular FN1) is an important component of the extracellular matrix and is secreted (mostly by fibroblasts) to regulate cell adhesion and migration, whereas in the liver, EDA is skipped, generating a soluble FN1 isoform that is secreted into the plasma (see the figure, left panel). Plasma FN1 is one of the main protein components of blood and is involved in blood clotting [129] [130] [131] [132] . Later, RNA sequencing systematically identified multiple other FN1 splicing events and their patterns in various developmental contexts. Finally, animal models revealed the functional impact of splice isoforms of FN1, demonstrating the roles of both EDA isoforms in normal organism physiology and at the same time revealing that these splicing transitions do not have a major impact on animal development (see the figure, right panel) 133 . Phenotypes in grey are features that are normal in these transgenic animals (FN1 splicing does not have a physiological impact), whereas those in pink are features that are altered in these transgenic animals (FN1 splicing has a physiological impact). In addition to the differential expression and activ ity of RBPs, another layer of regulation is provided by splicing frequently occurring cotranscriptionally 19, 20 , allowing a mechanistic interplay between the transcrip tional and splicing machineries [21] [22] [23] [24] 
. Alternative splicing outcomes can be affected by RNA polymerase II (Pol II) kinetics, which can be controlled by chromatin modifications, chromatin structure and nucleosome occupancy 21 . This indicates that epigenetic modifica tions and alternative splicing can be coupled
. The transcriptional machinery has also been shown to recruit splicing factors that in turn promote or inhibit exon inclusion 21, 25 . Both scenarios can be combined: a slow Pol II can favour the recruitment of specific RBPs that promote exon inclusion or skipping, whereas a fast Pol II will hamper that recruitment 21, 26 . Specific examples that provide evidence for this coupling during development are discussed later in this Review.
The functional consequences of alternative splicing have been substantially less well explored than its mech anisms, and only limited examples have been studied in depth. Nevertheless, during the past decade, the splicing targets of RBPs have been identified using highthrough put methods and transgenic animals in which RBPs are induced or depleted in specific tissues. The main goals of these studies are to identify the splicing targets of individual RBPs and their binding sites in develop mental contexts, characterize the function of the RBPs in splicing coordination, and then infer potential roles of these splicing networks for tissue and organ development. Rescue experiments can then be used to reintroduce specific splicing isoforms into animal models in which RBP expression, and hence splicing isoform composition, has been altered, confirming the functions of particular splicing isoforms. As a result of these studies, we now have a greater understanding of the function of specific splicing events in development. In the next sections we describe some of the most notable recent examples that demonstrate the impor tance of alternative splicing for proper development and tissue homeostasis.
Splicing in the brain
Embryonic neural progenitor cells differentiate into neurons, which after migration to their final destination gradually form neuronal circuits that serve as the basis for information processing and behavioural control. A transcriptome data set from mouse fetal and adult cerebral cortex has been described, including data on alternative splicing isoforms 13 . In this study, adult cere bral cortex and embryos exhibited almost 400 different alternative splicing events, and 31% of the genes that were found to be differentially regulated by alterna tive splicing during development did not change their total expression levels 13 . This finding suggests that the generation of alternative mRNA isoforms is the major [27] [28] [29] [30] [31] . In particular, PTBP1 and PTBP2 engage in a crosstalk, whereby in neuronal progenitors PTBP1 represses the inclusion of PTBP2 exon 10, lead ing to exon skipping and a transcript with a premature termination codon (PTC) and NMD [32] [33] [34] . As cells exit the cell cycle to differentiate into neurons, PTBP1 is downregulated, whereas SRRM4, which acts as a pos itive regulator of PTBP2 splicing, is upregulated, and this promotes PTBP2 exon 10 inclusion. As a result, PTBP2 is expressed, promoting neuronal development and tissue maintenance 29, 30, [32] [33] [34] [35] . Interestingly, PTBP2 has a broader role in the development of the mammalian neocortex, as it is also expressed in neural progenitors, in which it is responsible for repressing the inclusion of adult pecific alternative exons in genes encoding pro teins that control cell fate, proliferation and the actin cytoskeleton 27, 28 . Another mechanism of splicing regula tion by RBPs in neuronal differentiation is through their own alternative splicing changes during development. This occurs with RNAbinding protein FOX1 homo logue 1 (RBFOX1) -an RBP that has been associated with both neuronal differentiation 36 and neurodevelop mental programmes that control synaptic functions 37 . Exon 19 of RBFOX1 is alternatively spliced by RBFOX proteins, giving rise to nuclear (excluding exon 19) or cytoplasmic (including exon 19) protein isoforms. In RBFOXdepleted neurons, more than 500 alterna tively spliced cassette exons were misregulated, leading to significant changes in the level of exon inclusion or skipping in comparison with the control condition. Exogenous introduction of the nuclear isoform rescues these splicing changes, probably by binding to the GCAUG motifs in the proximal intronic region down stream of the regulated exons. By contrast, expression of the cytoplasmic variant rescues changes in mRNA levels of synaptic and autismrelated genes through mRNA stabilization mechanisms (3ʹ UTR binding and competition with microRNAs) 38 (FIG. 1a) .
PTBP and RBFOX proteins can exert antagonistic splicing actions that control neurogenesis. In neuronal progenitor cells, PTBP1 maintains the lamination of neural progenitor cells by promoting the skipping of the poison exon, exonN (which is 57 nucleotides long) in filamin A transcript. ExonN inclusion intro duces a PTC that results in a truncated protein and/or NMD 31 . Conversely, RBFOX proteins promote neuronal differentiation through the splicing switch of ninein exons 18 (2,000 nucleotides) and 29 (61 nucleotides)
Box 2 | Key regulators of alternative splicing coordination
The figure shows different players in the control of tissue-and developmental-stagespecific alternative splicing at the post-and co-transcriptional levels.
RNA-binding proteins (RBPs) regulate alternative splicing through their expression level, intracellular localization, activity and, in some cases, their own alternative splicing. RBPs promote or inhibit the recognition of alternative regions by the spliceosome machinery. Multiple RBPs can regulate alternative splicing in a cooperative or competitive manner 15 and also exert their regulatory functions by coupling with other splicing regulators (such as the transcriptional machinery or epigenetic readers). The expression levels of RBPs are tightly regulated during organ development and cell differentiation. Tissue-and cell-type-specific RBP expression patterns give rise to different splicing products 18 . Therefore, the modulation of splicing transitions through RBPs is one of the main mechanisms of splicing coordination, particularly during development, and the role of RBPs in regulating developmental splicing transitions has been intensively studied (Supplementary information S1 (table)).
Alternative splicing outcomes can be modulated also by other means, including transcription and epigenetic changes. It has been shown that RNA polymerase II (Pol II) elongation rates, which are controlled by chromatin modifications, DNA methylation and nucleosome occupancy, can greatly influence splicing. When elongation rates are reduced, weak splice sites are better recognized and alternative exons tend to be included; by contrast, when Pol II elongation is enhanced, the recognition of weak splice sites is impaired and alternative exons tend to be skipped 18 . However, slow Pol II can favour the recruitment of specific RBPs that promote exon inclusion (positive regulators) or skipping (negative regulators), whereas fast Pol II hampers that recruitment 18, 23 . Increased nucleosome occupancy, Pol II pausing, DNA methylation and specific histone marks at exons relative to introns support the idea that these epigenetic signatures can also help the splicing machinery to recognize alternative exons 18, 22 . Indeed, global correlations are being demonstrated between splicing patterns and specific histone marks, DNA-methylation patterns, nucleosome occupancy, Pol II positioning and RBP binding 45, 46, 48, [134] [135] [136] [137] [138] [139] . However, whereas splicing regulation by RBPs has been extensively studied and demonstrated in a developmental context, the developmental data on the coupling between splicing events and transcription machinery and epigenetic modifications are much more limited. CTCF, CCCTC-binding factor.
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Filamin A
An actin-binding protein that is involved in the crosslinking of actin filaments, cytoskeleton remodelling, cell shape and cell migration.
Ninein
A protein involved in the anchoring of microtubule minus-ends and in centrosomal functions.
from a centrosomal nonneuronal isoform to a non centrosomal neuronal variant that is associated with microtubules 31 . In summary, the autoregulatory loops of RBPs are another mechanism of splicing control during development.
The functional consequences of alternative splicing have been convincingly documented in neuronal differentiation. Neurooncological ventral antigen 2 (NOVA2) is a splicing regulator that is implicated in brain and vascular development, in which it controls cell polarity [39] [40] [41] . In the brain, NOVA2 exerts this function by controlling disabled homologue 1 (DAB1) splicing. DAB1 is an adaptor protein that is involved in reelin signalling, an important pathway in the develop ment of the mammalian cortex 42, 43 . When exons 7b and 7c are included in DAB1, the protein becomes more stable. This longer isoform also interferes with the function of its shorter form, which is important for regulating neuronal migration. Expression of the long isoform of DAB1 in neurons (which express the short, alter natively spliced isoform) induces neuronal migration defects that are similar to those observed in Nova2 44 . Another axis connecting one RBP with a specific splicing event and a clear functional consequence in brain development has been demonstrated recently in an elegant manner. The RBP Sam68like mammalian protein 2 (SLM2; also known as KHDRBS3) has been found to control the functional specification of gluta matergic synapses in mouse hippo campus through alternative splicing. Slm2 −/− mice exhibit impaired synaptic plasticity and behavioural defects that are res cued by genetic correction of a single Slm2dependent alternative spliced region in the neurexin 1 (Nrxn1) gene 45 . This segment is known in the field as alter native spliced segment 4 (AS4), which is spatio temporally controlled in murine brains and responds to neuronal activity 46 .
Alternative splicing and epigenetic landscapes. As mentioned above, there is evidence that alternative splicing and epigenetic regulation of chromatin are coupled. This seems to be the case in the developing brain, in which alternative splicing of precise chro matin remodellers has been shown to affect neuronal differentiation and neurite morphogenesis 24, 47 . It has also been shown recently that neuronal differentiation responds to alternative splicing of euchromatic histone lysine methyltransferase 2 (EHMT2; also known as G9a and KMT1C), an enzyme that controls histone H3 Lys9 mono and dimethylation (H3K9me1 and H3K9me2, respectively). The generation of an EHMT2 isoform harbouring alternatively spliced exon 10 increases dur ing the differentiation of a mouse neuroblastoma (N2A) cell line, and also during mouse brain development. This alternative splicing event enhances H3K9me2 levels without altering enzyme catalytic activity, prob ably through favouring EHMT2 nuclear localization. The presence of exon 10 does not alter EHMT2 protein domains, but the exon is adjacent to a nuclear localiza tion signal (NLS) 48 , so its inclusion might favour expo sure of the NLS 24 . The exon10containing isoform is required for neuronal differentiation, most probably by increasing H3K9 methylation levels. It also regulates its own splicing, promoting the inclusion of exon 10 and generating a positive feedback loop that further reinforces commitment to differentiation 24 (FIG. 1c) . Lys specific histone demethylase 1 (LSD1; also known as KDM1) is also alternatively spliced, and an isoform con taining exon 8a (encoding four amino acids) is speci fic to the nervous system. Expression of neural LSD1 iso form containing exon 8a in cultured cortical neurons reduced LSD1 activity as a transcriptional repressor. Depletion of this neurospecific isoform inhibited neu rite maturation, whereas overexpression enhanced it. By contrast, experimental changes of the expression of LSD1 isoforms lacking exon 8a had no effect on neurite morphogenesis 47 . More recently, an LSD1 isoform con taining exon 8a has been shown to mediate H3K9me2 demethylation by interacting with the protein super villin. Depletion of the LSD1+8a isoform led to an increase in H3K9me2 and thus changes in specific gene expression programmes, which in turn altered neuro nal differentiation 49 . This collectively demonstrates that alternative splicing can have an impact on the epi genetic landscape of the cell, thereby modulating gene expression programmes.
The opposite scenario, whereby epigenetic changes influence splicing outcomes, has also been documented in the brain. Global genomic studies have shown that DNA methylation is enriched in exons 50, 51 but, interest ingly, lower levels of DNA methylation were detected in skipped exons than in those included 52, 53 . In addi tion, the GC content of exon-intron boundaries has been shown to affect splicing outcomes [54] [55] [56] , which sug gests that DNA methylation regulates splicing events. One interesting example of this regulatory para digm has been described recently in brain development in honey bees (Apis mellifera). The development of a larva into a queen or worker honeybee depends on nutri tion, which in turn affects DNA methylation levels 57 (FIG. 1d) . DNA methyltransferase 3 (Dnmt3) silencing in embryos generates adult queen bees, demonstrating that DNA methylation controls caste determination (with demethyl ation promoting queen development) 57 . Adult queen and worker honeybees have different brain methylomes. Interestingly, spliceosome components and splicing factors are enriched in the group of differ entially methylated genes, and alternative splicing has been shown to be more prevalent in methylated than in nonmethylated spliced genes 58, 59 , indicating that in these animals, DNA methylation and alternative splicing are closely associated. Among the differentially methylated genes was anaplastic lymphoma kinase (Alk), which encodes a metabolic regulator and under goes extensive alternative splicing 59 . Alk is differentially methylated between queens and workers mostly within intron 25 and exon 9 (REF. 59 ). Low intron 25 methyl ation correlates with exon 25 inclusion 59 . A similar mechanism has been described in mammalian B cells, in which differential methylation affects splicing of exon 5 of the CD45 cellsurface molecule. In more detail, CCCTCbinding factor (CTCF) promotes exon 5 inclusion when bound to chromatin by inducing Pol II pausing at the intron-exon boundary; DNA methyl ation inhibits CTCF binding, thereby preventing exon 5 inclusion 60 . CTCF also promotes the inclusion of weak upstream exons on a more global scale, also through mediating Pol II pausing 60 , and CTCFbinding sites are highly conserved between tissues 61 . Therefore, developmental DNA methylation might contribute to tissuespecific splicing 60 . This mechanism is rele vant in diseases such as cancer, in which global DNA methylation and CTCFbinding changes occur together with the misregulation of splicing networks 60 . Nature Reviews | Molecular Cell Biology 
Frontotemporal lobar degeneration
A disease caused by progressive damage to and atrophy of the temporal and/or frontal lobes of the brain.
Perturbation of alternative splicing networks in neurological disorders. Aggregation of the RBP TAR DNA binding protein 43 (TDP43) is the pathological hall mark of amyotrophic lateral sclerosis and frontotemporal lobar degeneration [62] [63] [64] [65] [66] [67] [68] . TDP43 regulates the levels of its own mRNA and protein by a self regulatory loop. Excess TDP43 results in increased binding to the 3ʹ UTR of its mRNA and the splicing of a normally silent 3ʹ UTR intron. A second, rarely used polyadenylation site is located downstream of this 3ʹ splice site. The proximity between the spliceosome assembled in that splice site and the polyadenylation complex induces disruptive interactions, the splicing process is thus aborted, and the partially processed premRNA is degraded, allowing regulation of TDP43 expression 69 . In a patho logical state, TDP43 accumulates in neurons, depleting the nucleus of this protein. The TDP43 selfregulation loop detects low TDP43 nuclear levels and increases mRNA prod uction. In consequence, aggregates become larger and entrap further newly synthesized TDP43. Consequently, the splicing of TDP43 targets is altered 64, 70 . In particu lar, the missplicing and expression of genes involved in neuromuscular junction maintenance are controlled by TDP43.
Global misregulation of splicing networks has been shown in autism spectrum disorder (ASD). Mutations in RBFOX proteins are present in people with autism and alter the splicing of transcripts involved in ASD, such as SH3 and multiple ankyrin repeat domains protein 3 (SHANK3), voltagedependent Ltype calcium channel subunit α1C (CACNA1C) and tuberous sclerosis 2 pro tein (TSC2; also known as tuberin) [71] [72] [73] . Furthermore, a splicing network in functionally related genes has been described to affect 'microexons' (3-15 nucleotides) . These microexons modulate the interaction domains of proteins that are involved in neurogenesis and are mainly regulated by SRRM4. Neural microexon inclu sion is misregulated in people with ASD through SRRM4 upregulation. As a result, in developing autistic brains, proteininteraction networks might be remodelled in comparison with normal neurogenesis programmes 74 .
A recent study has demonstrated the functional consequences of the unbalanced generation of different tau splicing isoforms. Tau is a microtubuleassociated protein that is involved in axonal transport and neurite growth. Exon 10 is alternatively spliced, generating two isoforms with three microtubulebinding repeats (3R) or four microtubulebinding repeats (4R). Imbalanced 3R/4R ratios are associated with neurodegeneration, as they impair intracellular transport of the Alzheimer diseaserelated amyloid precursor protein (APP) 75 . Brain development and neuronal differentiation are highly suitable models for studying the regulatory and functional aspects of alternative splicing in vivo. In this tissue, extensive alterations of splicing are translated into changes in specific protein isoforms during develop ment, and these alterations then affect key physiological processes such as neuronal differentiation, cell migra tion, synaptogenesis, synapse functions, motor neuron development and neuronal excitability 76 . These splicing networks are often controlled by RBPs that develop mentally change their expression levels but can also be modu lated by (and engage in the modulation of) epigenetic factors
Splicing in striated muscle
Striated muscle (heart and skeletal muscle) was one of the first tissues in which it was found that alterna tive splicing regulation increases protein complexity. Together with the brain, it is where most tissuespecific alternative splicing takes place 77, 78 .
Extensive alternative splicing transitions during cardiac development. The heart is the first organ to form and function during embryogenesis, and thus embryonic heart development has been very well studied at the transcriptional and posttranscriptional levels. However, the changes that occur in the heart postnatally were not deeply investigated until recently. These changes are extensive, as after birth the heart needs to adapt to largely different oxygen and metabolic conditions, and cardio myocytes mature to a very precise intracellular structure to be fully functional in adulthood (FIG. 2a) . These physio logical and morphological changes are mainly driven by transcriptional and posttranscriptional transitions. 19) in the RNA-binding protein FOX1 homologue 1 (Rbfox1) transcript is alternatively spliced, giving rise to nuclear (lacking e.19) and cytoplasmic (containing e.19) protein isoforms. In RBFOX-depleted neurons, the misregulation of splicing networks controlled by RBFOX1 leads to defects in the expression of transcription factors, other splicing factors and synaptic proteins. The introduction of exogenous nuclear RBFOX1 rescues changes resulting from the misregulation of splicing networks. The introduction of exogenous cytoplasmic RBFOX1 stabilizes multiple mRNAs (for example, by interfering with the binding of some microRNAs (mi RNAs)), particularly the mRNAs of synaptic and autism-related genes. This stabilization increases protein expression of the targeted genes, rescuing certain neuronal functions. b | During brain development, disabled homologue 1 (DAB1) undergoes a transition from a long to a short isoform, which involves the skipping of exons 7b and 7c. This developmentally regulated splicing transition of DAB1 is under the control of the RNA-binding protein neuro-oncological ventral antigen 2 (NOVA2), which governs exon skipping. The DAB1 isoform containing exons 7b and 7c (DAB1-7bc) is more stable, and when misexpressed in adults, it antagonizes the short variant, inducing neuronal migration defects. Consistent with this, Nova2-knockout mice, as well as mice in which the DAB1-7bc isoform has been ectopically introduced, show defects in neuronal migration, and these defects are rescued by expression of the short DAB1 isoform. c | Alternative splicing of the chromatin remodeller euchromatic histone lysine methyltransferase 2 (EHMT2) regulates neuronal differentiation. EHMT2 exon 10 (e.10) inclusion increases during neuronal differentiation and favours EHMT2 nuclear localization. This leads to an increase in histone H3 Lys9 dimethylation (H3K9me2), a histone mark that is generally associated with transcription silencing. In this case, it is plausible that the increase in H3K9me2 might contribute to the repression of progenitor-specific genes. The isoform containing e.10 is thus required for neuronal differentiation through the promotion of e.10 inclusion in its precursor mRNA (pre-mRNA). In consequence, this positive feedback loop reinforces commitment to differentiation 24 . d | Honeybee larva development into a queen or a worker bee is regulated by DNA methylation (green pins represent methylation sites), which is influenced by nutrition (larvae developing into queens have lower DNA methylation levels, and differentiation into queens can be promoted by silencing DNA methyltransferase 3 (DNMT3)). Alternative splicing is more prevalent in methylated genes than in non-methylated ones. In particular, the intron between exons 25 and 26 in the pre-mRNA of anaplastic lymphoma kinase (Alk; a metabolic regulator with the capacity to enable growth in a nutrient-independent manner) is differentially methylated between queens and workers. Low methylation correlates with exon 25 inclusion and leads to the development of the larvae as queens. NLS, nuclear localization signal.
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During heart development, there are dramatic changes in the expression levels of multiple RBPs, including CUGBP Elavlike family member 1 (CELF1), muscle blindlike protein 1 (MBNL1), RBFOX1, RBFOX2 and RNAbinding protein 24 (RBM24) 79 . The splicing targets of these RBPs have been identified using animal models in combination with genomewide approaches 5, 11, [80] [81] [82] (Supplementary information S1 (table)). In a similar way to the situation in the brain, during heart develop ment RBPs can engage in cooperative and antagonistic actions (for example, CELF1 and MBNL1 were shown to antagonistically regulate alternative splicing in heart development 80 ).
Microarray experiments have revealed splicing tran sitions during the differentiation of human embryonic stem cells into cardiac precursors 83 and in postnatal heart development 5 . More recently, the transcriptome dynamics of mouse cardiac ventricles, cardiomyocytes and cardiac fibroblasts at different postnatal stages have been described 11 . These analyses revealed that alternative splicing transitions in cardiomyocytes are concentrated during the first 4 weeks after birth, suggesting that cardio myocytes use splicing mechanisms for maturation 11 . By contrast, splicing transitions are not restricted to the first four postnatal weeks in cardiac fibroblasts and occur across the entire postnatal period. In cardiomyocytes, the genes that are most significantly regulated by alter native splicing are involved in vesicular trafficking and membrane remodelling 11 . Four of these splicing events were further shown to affect skeletal muscle functions and structure in vivo. Antisense oligonucleotides target ing splice sites in these transcripts induced a reversion of the adult splicing pattern to the fetal one when deliv ered into the foot muscles of adult mice. After splicing reversion, muscle force generation was reduced, calcium signalling was misregulated and internal cell architecture alterations were observed 84 .
Titin splicing contributes to the regulation of mechanical properties of the heart. In the heart, probably the beststudied splicing events are those occurring in titin (TTN). In mammals, the gene encoding TTN contains the highest number of exons of all known genes. Exons 50-219 are developmentally regulated: a 3.7 MDa pro tein (N2BA isoform) is primarily expressed in neonates, whereas in adults a shorter, 2.97 MDa isoform (N2B) is the most abundant 85, 86 . In cardiomyocytes, the amino terminus of TTN is located at the Z-line, and the carboxyl terminus is located at the M-line. Alternative exons encode part of the immunoglobulinlike region, the N2A portion and the PVEK region (rich in proline, glutamate, valine and lysine) 85 . This alternative region is known as the Iband. Sequence variability in the Iband region determines the elastic properties of the protein, thereby modulating the elasticity of the muscle (the longer the region, the more elastic the protein). Therefore, the ratio of N2BA (long isoform) to N2B (short isoform) deter mines sarcomere length and cardiomyocyte passive tension, and thus myocardium wall stiffness during ventricu lar filling 87 . TTN splicing in the Iband is regu lated by RBM20 (REFS 87-89), and mutations in RBM20 were identified in humans with dilated cardiomyo pathies [89] [90] [91] [92] [93] (FIG. 2b) . RBM20 regulates TTN splicing by a twostep sequential mechanism: first, before the splicing reaction starts, RBM20 binds the newly transcribed pre mRNA, blocking intron removal in bound regions, while the rest of the premRNA is spliced 87 ; and second, the partially spliced premRNA is retained in the nucleus and the 5ʹ and 3ʹ splice sites on the exons flanking the RBM20bound region are spliced together, leading to removal of that region 87 . Alternative splicing also occurs in the Mlineassociated portion of TTN. Here, splicing regulates the inclusion of the Mex5 exon, which encodes the specific is7 domain located between the Figure 2 | Alternative splicing in heart development. a | The heart is the first organ to form and function during embryogenesis, and prenatal heart development has been well studied at the transcriptional and post-transcriptional levels. Many changes in the heart also occur postnatally and are associated with the switch between different oxygen and metabolic conditions as well as changes in cardiomyocyte intracellular structure. These physiological and morphological changes are mainly driven by transcriptional and post-transcriptional transitions, including changes in the expression of RNA-binding proteins (RBPs) and splice isoforms. b | During heart development, RNA-binding protein 20 (RBM20) regulates the splicing of titin -a giant protein that is able to act as a molecular spring -with exons 50-219 being developmentally regulated [87] [88] [89] . In neonates, primarily long isoforms (N2BA) are expressed, whereas a shorter isoform (N2B) dominates in adults. The alternatively spliced region of titin is known as the I-band, and controls titin elasticity (with longer regions promoting elasticity). The ratio between N2BA and N2B isoforms thus determines sarcomere length, cardiomyocyte passive tension and myocardium wall stiffness 87 . RBM20 mutations were identified in humans with cardiomyopathies, linking changes in titin alternative splicing to human pathology [89] [90] [91] [92] [93] . FN3, fibronectin type-3 domain; Ig, immunoglobulin-like; PVEK, region rich in proline, glutamate, valine and lysine. 
Myoblast fusion
Myoblast cells fuse with each other, forming multinucleated myotubes that generate muscle fibres (myofibres) during development.
immunoglobulinlike domains. Mex5 exon inclusion is muscletype, developmentalstage and speciesspecific, and its regulation is altered in myotonic dystrophy type 1.
Recently, a mouse model was generated using CRISPRCas9 editing to constitutively prevent the expression of isoforms containing the is7 domain. These animals exhibited a dystrophic phenotype in striated muscles (that is, the soleus and heart), which are tissues that exclusively express TTN isoforms containing the Mex5 exon. This demonstrates that alternative splicing of this region has tissuespecific functions 94 .
Perturbation of alternative splicing networks in heart diseases. In cardiac diseases, there is a global reversion to neonatal transcriptional programmes, accompanied by the adult heart reverting to neonatal oxygen consumption and metabolic programmes, and by severe alterations in the internal architecture and functionalities of cardio myocytes (FIG. 2a, right) . This overall reversion from adult to neonatal programmes is also associated with changes in the expression of multiple RBPs (including RBFOX, RBM20 and RBM24) and thus leads to the perturbation of their targets 79, 81, 95, 96 . In particular, a global hallmark of heart failure and cardiomyopathies is the reversion from adult to fetal alternative splicing patterns, particularly affecting the expression of proteins involved in RNA processing, cytoskeletal organization, development and metabolism 97 . Diverse examples have been reported in the literature, and one of the most recent was described in cardiac hypertrophy (TABLE 2) . Hypoxia, a hallmark of cardiac hypertrophy, induces the expression of splicing factor 3B subunit 1 (SF3B1), which in turn deregulates the splicing of two mutually exclusive exons of ketohexo kinase, biasing the generation of an isoform that is pri marily produced in the liver. Because ketohexokinase is the central fructosemetabolizing enzyme and is involved in glucose metabolism, missplicing promotes anabolic metabolism, leading to heart muscle overgrowth and severe cardiac contractile problems 98 .
Alternative splicing in skeletal muscle differentiation. Although more than 1,000 musclespecific splicing events have been mapped 99 , little is known about the regu latory mechanisms that drive skeletalmuscle specific splicing programmes in development. No genome wide data is yet available on splicing transitions during skeletal muscle development in vivo, but splicing net works operating during muscle cell differentiation have been identified in the murine myoblast cell line C2C12 (REF. 14) . Specific RBPs coordinate these splicing net works, including PTBP, quaking (QK) and RBFOX2 (REFS 14, 100, 101) . In particular, RBFOX2 controls numer ous splicing transitions, and its depletion leads to myoblast fusion defects. These abnormalities are partially rescued when differentiated cellspecific splicing isoforms of the transcriptional regu lator myocyte specific enhancer factor 2D (MEF2D) and the cytoskeleton regu lator RHO associated protein kinase 2 (ROCK2) are reintroduced 14 . Furthermore, it has been demonstrated that the ubiqui tous (MEF2Da1) and the musclespecific (MEF2Da2) splicing isoforms antagonistically regulate muscle cell differentiation 102 . Only MEF2Da2 activates late muscle gene transcription programmes as a result of its decreased susceptibility to phosphorylation. Protein kinase A phosphorylates MEF2Da1, leading to its associ ation with corepressors and thus preventing its activ ating role in transcription. By contrast, MEF2Da2 remains unphosphoryl ated and recruits the coactivator ASH2like protein (ASH2L), which is involved in the activation of musclespecific genes 102 .
Alternative splicing and myotonic dystrophy. Myotonic dystrophy is the most common muscular dystrophy in adults. People with myotonic dystrophy exhibit symp toms that affect different organs: muscle weakness, myopathy, insulin resistance, cardiac arrhythmias, hypogonadism and cataracts, among others 103 . Two main forms of this pathology exist, and are caused by the expansion of repeat sequences in the 3ʹ UTR of the dystrophia myotonica protein kinase (DMPK) gene (myotonic dystrophy type 1) or the first intron of the CCHCtype zinc finger nucleic acid binding protein (CNBP; also known as ZNF9) gene (myotonic dys trophy type 2). These expansions lead to the nuclear sequestration and/or deregulation of specific splicing factors. In myotonic dystrophy type 1, the RBP MBNL1 binds to the expanded repeats in the DMPK 3ʹ UTR in the nucleus, and thus its functionality as a transcrip tional and posttranscriptional regulator is reduced. The repeats in the 3ʹ UTR of DMPK also lead to CELF1 activation and the gain of CELF1 functions. One of the consequences of this molecular mechanism is that CELF1 and MBNL1 splicing targets are misregulated and adult tissues (mainly the brain, heart and skele tal muscle) express fetal protein isoforms. Embryonic protein variants are functionally efficient in fetal and neonatal organs and cells, but in adult tissues they do not fulfil the functional requirements. Therefore, the misregulation of alternative splicing directly contrib utes to the pathological features observed in people with myotonic dystrophy (TABLE 2) . For example, mis splicing of insulin receptor exon 11 reduces the metabolic insulin response 104, 105 . Muscle weakness is proposed to be a consequence of misregulated calcium signalling as a result of the missplicing of genes encod ing ryanodine receptor 1 (RYR1; exon 70), ATPase sarcoplasmic/endoplasmic reticulum calcium trans porting 1 (ATP2A1; also known as SERCA1; exon 22), voltagedependent Ltype calcium channel subunit α1S (CACNA1S; exon 29) and MYC boxdependent interacting protein 1 (BIN1; exon 11) 106, 107 . Myotonia (prolonged muscle contraction) is attributed to abnor mal inclusion of exon 7a in chloride channel protein 1 (CLCN1) in muscle, which produces a frameshift and a nonfunctional protein. Approximately 80% of people with myotonic dystrophy also develop cardiac dysfunc tion. Analysis of samples from the hearts of people with myotonic dystrophy type 1 revealed a global deregula tion of splicing networks that affects genes encoding ion channels and proteins involved in intracellular transport and cell architecture 108 . In particu lar, mis splicing of sodium channel protein type 5 subunit alpha (SCN5A) in the heart causes cardiac conduction defects and arrhythmias 108 . In summary, alternative splicing has an important role in the development and physiology of the heart and skeletal muscle. Alternative splicing regulates the properties of proteins that exert precise actions in these tissues: ion transport, structural functions, excitationcontraction coupling and metabolism. As a result, mis regulation of splicing networks in these tissues can lead to major diseases.
Splicing in other tissues and organs
The brain and striated muscle are the beststudied tissues in terms of the impact of alternative splicing on physiology. Nevertheless, there are several interesting examples of functional roles of alternative transcripts and splicing networks in other systems.
Splicing responses in the pancreas. To our knowledge, there is scant developmental transcriptome data for the pancreas. Only a few splicing networks have been described to date, and these are regulated by inflam matory cytokines 109, 110 and fatty acids 111 . One of these networks is coordinated by NOVA1 and affects genes involved in exocytosis, apoptosis, insulin signalling and transcription regulation 110 . Another splicing pro gramme is coordinated by RBM4. RBM4 depletion in mice induces metabolic alterations and the missplicing of factors that are required for pancreatic cell differ entiation and function. In particular, RBM4 regulates alternative splicing of the transcription factors ISL1 and paired box 4 (PAX4), which in turn modulate insulin gene expression 112 .
Alternative splicing transitions in liver development and maturation. The liver develops from an embry onic haematopoietic tissue to a metabolic adult organ. Hepatocytes, the major hepatic parenchymal cell type (>75% liver volume), switch from highly proliferative to quiescent stages, and misregulation of this quiescence can lead to hypertrophic growth during postnatal life. Early studies demonstrated the molecular mechanisms by which different splicing factors regulate liver develop ment, homeostasis and metabolism in health and dis ease. For example, Ser and Argrich splicing factor 3 (SRSF3) is required for hepatocyte differenti ation 113 , SRSF10 has been implicated in obesity through its role in regulating lipogenesis 114 and SLU7 is essential for liver homeostasis 115 . More recently, coordin ated, celltype specific (hepatocytes versus nonparenchymal cells) transcriptional and posttranscriptional transitions were shown to drive postnatal liver remodelling and matur ation 12 . In liver, postnatal development RBPs are mostly downregulated 12 . Epithelial splicing regulatory pro tein 2 (ESRP2) is one of the few RBPs that is post natally induced, and it regulates a conserved set of splicing tran sitions specifically in hepato cytes, governing hepatocyte terminal differentiation and maturation 12 . Splicing and epigenetics in germline development. During development, the cells that will become gametes need to differentiate into primordial germ cells and migrate to the proper location to form the animal germ line. Not much is known about alternative splicing during ovarian germline development. What is known is that during ovary development, alternative splicing regulates Rbfox1 localization and thus modulates its cellular functions. Recent rescue experiments in Drosophila melanogaster showed that two specific cytoplasmic Rbfox1 splicing iso forms are responsible for germ cell differentiation during early germline cyst development 116 . Cytoplasmic Rbfox1 isoforms repress the translation of mRNAs containing (U)GCAUG elements in their 3ʹ UTRs, including the mRNA of Pumilio -a protein that drives germline stem cell maintenance by repressing the translation of speci fic mRNAs 117 . In consequence, Pumilio repression pro motes germ cell differentiation. Therefore, cytoplasmic Rbfox1 acts as a genetic barrier to prevent the reversion of germline cysts back to earlier developmental stages 116 . Regulation of splicing is also important for sperma togenesis, and in this scenario, interplay between epi genetics and splicing and between transcription and splicing has been proposed
. Spermatogenesis occurs in the seminiferous tubules, where postnatal male germ cells develop. The mammalian testis is among the tissues with the highest transcriptome complexity, includ ing alternative splicing regulation 118, 119 . Extensive splicing transitions occur during the progression from mitotic spermatogonia to meiotic spermatocytes 120 . Most of these changes affect conserved proteincoding exons 120 , sug gesting a large impact of these transitions on the physio logical functions of the alternatively spliced protein isoforms. Numerous RBPs are differentially expressed during spermatogenesis, and flanking sequences of the regulated alternative exons are enriched for binding sites for PTBP1, PTBP2, transformer 2 protein homologueβ (TRA2B) and steroidogenic acute regulatory protein (STAR) family proteins 120 . Whereas PTBP1 is mainly expressed in spermatogonia (mitotic cells), PTBP2 predomin ates in meiotic spermatocytes and postmeiotic spermatids 120, 121 . PTBP2 is essential for mouse spermato genesis and for alternative splicing coordination in the testis (and, as discussed above, for neuronal differenti ation in the brain) 121 . During spermatogenesis, chroma tin structure transitions from a closed to a more open state, and this enables the majority of the genome to be transcribed in spermatocytes and spermatids 118 . Male germ cell development is one of the physiologi cal contexts in which transcription-splicing coupling has been elegantly demonstrated. In vivo, SRCassociated in mitosis 68 kDa protein (SAM68; also known as KHDRBS1), which binds to transcriptionally active chromatin in spermatocytes, modulates the splicing of exon 8 in epsilonsarcoglycan (SGCE). Molecularly, this regulation occurs through SAM68 binding to the intron-exon junction in SGCE exon 8, which results in the recruitment of phosphorylated Pol II, and at the same time interferes with the recruitment of the splicing factor U2 auxiliary factor 65 kDa subunit (U2AF65), leading to exon 8 skipping 122 .
A pioneering study has shown that in cell culture, the adaptor protein MORFrelated gene 15 protein (MRG15; also known as MORF4L1) binds to H3K36me3 and recruits PTBP1, which in turns promotes skip ping of exon IIIb in fibroblast growth factor receptor 2 transcript 123 . Recently, a similar splicing-epigenetics interplay has been demonstrated during spermato genesis 124 . Knockout mice lacking MRG15 specifically in postnatal male germ cells exhibit spermatogenic arrest at the round spermatid stage (just before termi nal differentiation into mature spermatozoa) and are thus sterile 124 . MRG15 depletion triggers the removal of specific mRNA sequences in transcripts and at the same time results in the retention of specific intronic sequences in the mRNAs of four genes 124 . One of these intronic retentions occurs in nuclear transition protein 2 (TNP2), which, together with other nuclear transition proteins, replaces histones during chromatin conden sation in maturing sperm. Nuclear transition proteins are later replaced by protamines, and this allows optimal chromatin packaging that enables proper elongation of the sperm head. In normal round spermatids, MRG15 colocalizes with PTBP1 and PTBP2 at H3K36me3 sites between the two TNP2 exons, and the intron is correctly removed, generating a functional TNP2 protein. By con trast, when MRG15 is absent, PTBPs are not recruited to the splicing machinery on the Tnp2 gene, and the intron is retained, leading to a drastic reduction in TNP2 protein levels 124 (FIG. 3a) .
Crosstalk between splicing, signalling and T cell activ ation. The human immune system relies on the ability of T cells to respond to antigens on antigen presenting cells, which triggers extensive changes in protein expression and cell activation. These transitions occur through transcriptional and posttranscriptional gene expression changes. Global splicing networks are coordin ated during T cell activation through specific signalling pathways, nucleosome occupancy and RBPs, including hetero geneous nuclear ribonucleoprotein L (HNRNPL) 125, 126 , polypyrimidine tractbinding protein associated splicing factor (PSF; also known as SFPQ) 127 and CELF2 (REFS 10, 128, 129) . Recent RNAsequencing experiments have revealed that global intron retention programmes might regulate T cell activation. During T cell activation, intron retention is globally reduced, and this correlates with an increase in mRNA steady state levels. Because most of the genes that are upregu lated during T cell activ ation show a reduction in intron retention, it has been proposed that the quick responses of T cells to acute extracellular signals are regu lated post transcriptionally and that alternative splicing has an important role in this 130 . The regulation of T cell activation by splicing involves a feedback loop between CELF2 and the c-Jun N-terminal kinase signalling cascade (JNK signalling cascade). T cell activation induces skip ping of exon 2 in dual specificity mitogenactivated pro tein kinase kinase 7 (MKK7; also known as MAPKK7), which introduces an additional site for JNK docking that is absent in the larger isoform. In consequence, proteinprotein interactions are promoted and the JNK pathway is enhanced. This then induces CELF2 mRNA stabiliza tion and upregulates CELF2 protein expression. CELF2 binds upstream of MKK7 exon 2 and further promotes its skipping, resulting in a positive regulatory feedback loop that amplifies JNK activity, which in turn promotes T cell differentiation and cytokine production 128, 129, 131 (FIG. 3b) .
HNRNPL mostly causes exon skipping, and this occurs when it is bound within cassette exons or to their flanking regions owing to the presence of specific exon silencing sequences 132, 133 . One of the targets of HNRNPL in T cells is CD45, which is an important cellsurface mol ecule in T cell differentiation and activation. CD45 under goes HNRNPLdependent alternative splicing, leading to exon 4 skipping after T cell activation 133 . Furthermore, exon skipping in CD45 premRNA is simultaneously promoted by PSF 127 . Interestingly, HNRNPL can also positively regulate the inclusion of some exons in T cells. These exons share sequence and context features: they are flanked by short GCrich introns but are not themselves GCrich. Consequently, the typical high GC differential between exons and introns (high GC in exons but low GC in introns) is absent in these exons 132 . These 'low GC dif ferential exons' exhibit poor nucleosome occupancy and are more likely to be skipped 54 . Evidence suggests that HNRNPL depletion results in reduced nucleosome occu pancy, so HNRNPL might prevent the skipping of low GC differential exons through an epigenetic mechanism that involves the regulation of nucleosome occupancy. It is also likely that HNRNPL promotes exon retention by enhancing the recognition of low GC differential exons by, for example, the transcription machinery 132 .
Splicing and cell differentiation
Studies of the mechanisms of cell differentiation and dedifferentiation (transition from a differentiated state to a proliferative one) have also provided novel know ledge of the functional impact of splicing regula tion. In particular, it has been shown that NMD is an important regulator of cell fate transitions.
Concerted splicing programmes leading to PTCs and NMD regulate smooth muscle cells. The plasticity proper ties of smooth muscle cells contribute to cardio vascular physiology, and their phenotypes range from contractile (blood vessels) to more synthetic and secre tory (atherosclerosis and arterial injury). During the dedifferentiation of primary aorta cells, extensive splicing transitions occur with little change in the mRNA levels These animals exhibit spermatogenic arrest and sterility. MRG15 depletion triggers intronic segment retentions, and one of them occurs in transition nuclear protein 2 (TNP2). In normal round spermatids, MRG15 binds to histone H3 Lys36 trimethylated (H3K36me3) sites between TNP2 exons 1 and 2 (e.1 and e.2). It recruits the RNA-binding proteins polypyrimidine tract-binding protein 1 (PTBP1) and PTBP2 to these sites, enabling the correct removal of the intron, which generates a functional TNP2 protein. TNP2 and other, related proteins then replace histones in the chromatin of maturing sperm, and are eventually replaced by protamines, which allow optimal chromatin packing for the sperm-head elongation observed in mature sperm. When MRG15 is absent, PTPB2 is not recruited and the intron is retained, leading to a drastic reduction in TNP2 protein levels and the arrest of spermatogenesis at the round spermatid stage. b | A positive regulatory feedback loop between c-Jun N-terminal kinase (JNK) signalling and splicing in T cell activation. This feedback loop includes the CELF2 splicing factor, which is responsible for alternative splicing of mitogen-activated protein kinase kinase 7 (MKK7; also known as MAPKK7). T cell activation induces CELF2-mediated MKK7 exon 2 skipping. This generates a shorter MKK7 isoform that harbours an additional JNK-docking site, which enhances JNK activity and JNK signalling. Enhanced JNK signalling induces CELF2 mRNA stabilization and protein upregulation, and so CELF2 levels increase with sustained T-cell activation, establishing a positive regulatory feedback loop 128, 129, 131 . Part a is adapted from REF. 124 . of RBPs. This evidence suggests that splicing programmes might be orchestrated at an additional level 15 . An impor tant piece of the splicing programme involves exons that are skipped during dedifferentiation. This repression is mediated by PTBP1, which is upregulated twofold during dedifferentiation 15 . PTBP1 is thus responsible for repressing multiple smoothmusclespecific exons in proliferative stages, and its downregulation during differentiation can be expected to be a key driver of the expression of smoothmusclespecific genes 15 . In addition, differentiated cells exhibit more frequent intron retention, the inclusion of poison exons that introduce PTCs, and alternative usages of polyadenylation. These concerted events lead to protein downregulation due to NMD, protein truncation or RNA nuclear retention and mostly affect genes encoding splicing factors, splicing regulatory kinases and other transcriptional regulators 15 .
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Alternative splicing and PTCs in erythropoiesis. During erythropoiesis, erythroid progenitors mature into red blood cells (erythrocytes). Starting with haemato poietic stem cell differentiation, a finely orchestrated transcrip tional and posttranscriptional programme drives the synthesis of the appropriate stagespecific proteome to fulfil the functions of progressively more special ized cells 134 . In erythroid cells, the beststudied splicing event is the stagespecific switch of exon 16 (inclusion versus skipping) in the gene encoding protein 4.1R, which mechanically stabilizes erythrocyte membrane. A decrease in HNRNPA/B expression during erythro poiesis mediates this splicing switch 135 . Microarrays identified several alternatively spliced cassette exons and alternative first exons during erythropoiesis 134 . This study also revealed that various RBPs, including small nuclear ribonucleo protein U1 subunit 70 (SNRP70), HNRNPLlike (HNRPLL) and MBNL2, are also regu lated by splicing mechanisms during erythropoiesis, demonstrating a regulatory feedback loop 134 . More recently, coordinated splicing networks operating during terminal erythropoiesis have been described using RNA sequencing, and MBNL1 was shown to act as a regulator of splicing transitions in this network 136 . Genes regulated by alternative splicing during erythropoiesis were shown to be involved in trans membrane receptor activity, chro matin modification, RNA binding and processing, and DNA repair packaging 136 . In particular, during mouse erythroid terminal development, MBNL1 promoted the inclusion of a 35 nucleotide cassette exon in nuclear dis tribution protein nudElike 1 (Ndel1). The retention of this alternative exon changes the protein C terminus and can influence NDEL1 interactions with other proteins. Only an NDEL1 isoform containing this alternative exon could partially rescue the differentiation defects observed after NDEL1 depletion, which, importantly, are similar to those observed when MBNL1 is absent 136 . Another study used RNA sequencing to investigate the transcriptional landscape of distinct human erythroblasts representing the last four cell divisions before terminal differenti ation (demarcated as cell enucleation) 137 . Interestingly, it was revealed that switches between splicing isoforms in these differentiating erythro blasts introduce PTCs into a group of transcripts and that this occurs in a differentiation stagespecific manner 137 . Recently, these discoveries have been expanded on with the demonstration that a dynamic intron retention programme that affects RNAprocessing genes is responsible for regulating gene expression during terminal erythropoiesis 138 .
In conclusion, the coupling between alternative splicing and PTCs and/or NMD emerges as a regulator of the genes expressed during cell differentiation. This con certed programme mainly affects genes that encode RNA processing regulators, thereby amplifying the functional consequences of alternative splicing.
Conclusion and perspectives
Global transcriptomic studies in recent years have extended the description of coordinated transitions between splicing isoforms in different tissues. The field is currently moving towards understanding the physio logical roles of specific splicing isoforms, particularly during development, when changes between alternatively spliced isoforms are especially common. However, more effort is required to fully understand the functional roles of developmental splicing networks. Thousands of protein isoforms derived from splicing changes associated with development need to be functionally characterized. The combined effort of numerous laboratories will be neces sary to achieve the complete characterization of the roles of specific splicing isoforms and networks in develop mental processes. Another challenge is that in multiple cases, dramatic splicing changes lead to only a slight physio logical impact. Therefore, great care should be taken when drawing conclusions, and it is important to combine genomewide approaches with molecular stud ies of different systems to fully determine the functional impact of developmental alternative splicing transitions.
We envision that future directions in this exciting field will be centred on three main aspects: gaining fur ther understanding of the regulation and coordination of splicing events by, for example, epigenetic modifica tions and transcriptionrelated events; uncovering the physiological functions of individual splicing isoforms (which is still an underexplored area in comparison with regulatory mechanisms); and finally, understanding how splicing networks as a whole govern development and tissue homeostasis.
